CRYO CELL INTERNATIONAL INC (CCEL): Nasdaq/NYSE listing notice — Cryo-Cell receives NYSE American delisting notice over stockholders' deficit and net losses

CRYO CELL INTERNATIONAL INC

NYSE American cited stockholders' deficit as of Nov 30, 2025 and net losses in two of three fiscal years ended Nov 30, 2025.
Company must submit compliance plan by April 8, 2026; if accepted, extension up to 18 months possible.
Trading of CCEL common stock continues on NYSE American while company pursues compliance plan.
No assurance that plan will be accepted or that compliance can be regained; delisting possible if not.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

CRYO CELL INTERNATIONAL INC received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)).

Exchange: nyse american
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 1003(a)

Exact text from the filing

March 9, 2026, Cryo-Cell International, Inc. (“Cryo-Cell”) received a written notice (the “Notice”) from NYSE American LLC (“NYSE American”) indicating that the Company is not in compliance with the continued listing standards set forth in Section 1003 (a) of the NYSE American Company Guide. The Notice has no immediate effect on the listing or trading of the Company’s common stock, which will continue to trade on the NYSE American under the symbol “CCEL” while the Company pursues a plan to regain compliance. In accordance with NYSE American procedures, the Company intends to submit a plan of

View on SEC.gov

Browse all listing & compliance notices →

CRYO CELL INTERNATIONAL INC filing history →

Source: SEC EDGAR

accession 0001193125-26-104392

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.